De Hertogh R, Ekka E, Vanderheyden I
J Steroid Biochem. 1986 Jun;24(6):1171-7. doi: 10.1016/0022-4731(86)90379-1.
Type II estradiol binding sites characterized by lower affinity and higher capacity than type I receptor sites have been described in rat uterine nuclei. These sites appeared to be dependent on estrogen stimulation. Reducing agents prevented estradiol binding to these sites. In the present study, the situation prevailing in adult rats (Ad) was studied and compared to ovariectomized (Ox) and ovariectomized estrogen prestimulated rats (OxPS). Nuclear precipitate from Ad, Ox and OxPS rats were incubated with tritiated estradiol (E2(3)H) in the presence and in the absence of mercaptoethanol as reducing agent. In the presence of mercaptoethanol, saturation was attained at E2(3)H concentrations above 16 nM. In the absence of reducing agents, a secondary binding was observed in Ad and OxPS which was not saturated at E2(3)H levels up to 80 nM. Non-specific binding obtained with paired aliquots containing 100-fold excess of DES as competitor was not linear but showed a saturation profile, distorting the saturation curve of the specific sites, obtained by subtracting non-specific from total E2(3)H binding. Increasing DES concentrations up to 10,000 nM did not allow to reach complete exchange with E3(3)H ligand bound to specific sites, preventing measurement of binding sites concentration. Incubation of nuclear fractions with increasing concentrations of E2(3)H (up to 6,000 nM) gave a saturation curve with a linear kinetics above 1-2,000 nM, which represented saturation concentration of the specific sites. From this, non-specific and specific moieties could be estimated. Binding capacity of specific sites was of the order of 50-80 pmol uterus. Half saturation was attained between 300 and 600 nM E2(3)H, which approximated the Kdiss of these sites, at variance with the Kdiss of 15-30 nM originally reported for type II binding sites. In conclusion, these results show that secondary binding sites were present in uterine nuclei of Ad and OxPS rats. Binding capacity was about 30-fold higher than that of type I sites. Affinity was however very low, and casts some doubt on the role of these sites as active estradiol binders in physiological situations. Their increase under the influence of estrogen may however be related to some as yet undetermined role.
在大鼠子宫核中已描述了II型雌二醇结合位点,其特征是与I型受体位点相比亲和力较低但容量较高。这些位点似乎依赖于雌激素刺激。还原剂可阻止雌二醇与这些位点结合。在本研究中,对成年大鼠(Ad)的情况进行了研究,并与卵巢切除(Ox)和卵巢切除并经雌激素预刺激的大鼠(OxPS)进行了比较。将Ad、Ox和OxPS大鼠的核沉淀物在有和没有作为还原剂的巯基乙醇存在的情况下与氚标记的雌二醇(E2(3)H)一起孵育。在巯基乙醇存在下,当E2(3)H浓度高于16 nM时达到饱和。在没有还原剂的情况下,在Ad和OxPS中观察到二级结合,在高达80 nM的E2(3)H水平下未达到饱和。用含有100倍过量己烯雌酚作为竞争者的配对等分试样获得的非特异性结合不是线性的,而是呈现出饱和曲线,扭曲了通过从总E2(3)H结合中减去非特异性结合而获得的特异性位点的饱和曲线。将己烯雌酚浓度增加到10,000 nM仍无法实现与结合到特异性位点的E3(3)H配体的完全交换,从而无法测量结合位点浓度。用浓度不断增加的E2(3)H(高达6,000 nM)孵育核级分,得到一条饱和曲线,在1 - 2,000 nM以上呈现线性动力学,这代表了特异性位点的饱和浓度。由此,可以估计非特异性和特异性部分。特异性位点的结合容量约为50 - 80 pmol/子宫。在300至600 nM E2(3)H之间达到半饱和,这近似于这些位点的解离常数(Kdiss),与最初报道的II型结合位点的15 - 30 nM的Kdiss不同。总之,这些结果表明在Ad和OxPS大鼠的子宫核中存在二级结合位点。结合容量比I型位点高约30倍。然而,亲和力非常低,这对这些位点在生理情况下作为活性雌二醇结合剂的作用提出了一些疑问。然而,它们在雌激素影响下的增加可能与某些尚未确定的作用有关。